Follow
Steven Pavletic
Steven Pavletic
National Cancer Institute, NIH
Verified email at croampro.com - Homepage
Title
Cited by
Cited by
Year
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working …
MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ...
Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015
4091*2015
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working …
MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ...
Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015
24462015
ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells
DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ...
Biology of blood and marrow transplantation 25 (4), 625-638, 2019
21282019
Risk factors for acute GVHD and survival after hematopoietic cell transplantation
M Jagasia, M Arora, MED Flowers, NJ Chao, PL McCarthy, CS Cutler, ...
Blood, The Journal of the American Society of Hematology 119 (1), 296-307, 2012
7882012
T cells genetically modified to express an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of poor-prognosis relapsed multiple myeloma
JN Brudno, I Maric, SD Hartman, JJ Rose, M Wang, N Lam, ...
Journal of Clinical Oncology 36 (22), 2267, 2018
6962018
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation
JN Kochenderfer, ME Dudley, RO Carpenter, SH Kassim, JJ Rose, ...
Blood, The Journal of the American Society of Hematology 122 (25), 4129-4139, 2013
6922013
Allogeneic T cells that express an anti-CD19 chimeric antigen receptor induce remissions of B-cell malignancies that progress after allogeneic hematopoietic stem-cell …
JN Brudno, RPT Somerville, V Shi, JJ Rose, DC Halverson, DH Fowler, ...
Journal of clinical oncology 34 (10), 1112, 2016
6392016
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft …
HM Shulman, D Kleiner, SJ Lee, T Morton, SZ Pavletic, E Farmer, ...
Biology of Blood and Marrow Transplantation 12 (1), 31-47, 2006
5202006
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic …
SZ Pavletic, P Martin, SJ Lee, S Mitchell, D Jacobsohn, EW Cowen, ...
Biology of Blood and Marrow Transplantation 12 (3), 252-266, 2006
4542006
The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in …
KR Cooke, L Luznik, S Sarantopoulos, FT Hakim, M Jagasia, DH Fowler, ...
Biology of Blood and Marrow Transplantation 23 (2), 211-234, 2017
4262017
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research
S Arai, M Arora, T Wang, SR Spellman, W He, DR Couriel, ...
Biology of Blood and Marrow Transplantation 21 (2), 266-274, 2015
4142015
Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD …
J Pidala, B Kurland, X Chai, N Majhail, DJ Weisdorf, S Pavletic, C Cutler, ...
Blood, The Journal of the American Society of Hematology 117 (17), 4651-4657, 2011
3812011
Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in …
D Couriel, PA Carpenter, C Cutler, J Bolaños-Meade, NS Treister, ...
Biology of Blood and Marrow Transplantation 12 (4), 375-396, 2006
3812006
Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic …
S O'Brien, JO Moore, TE Boyd, LM Larratt, A Skotnicki, B Koziner, ...
Journal of Clinical Oncology 25 (9), 1114-1120, 2007
3722007
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic …
SJ Lee, D Wolff, C Kitko, J Koreth, Y Inamoto, M Jagasia, J Pidala, ...
Biology of Blood and Marrow Transplantation 21 (6), 984-999, 2015
3572015
Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease
D Wolff, M Schleuning, S von Harsdorf, U Bacher, A Gerbitz, M Stadler, ...
Biology of Blood and Marrow Transplantation 17 (1), 1-17, 2011
3282011
EBMT− NIH− CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
HM Schoemans, SJ Lee, JL Ferrara, D Wolff, JE Levine, KR Schultz, ...
Bone marrow transplantation 53 (11), 1401-1415, 2018
3232018
Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD
D Wolff, A Gerbitz, F Ayuk, A Kiani, GC Hildebrandt, GB Vogelsang, ...
Biology of Blood and Marrow Transplantation 16 (12), 1611-1628, 2010
3072010
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis
RA Nash, JD Bowen, PA McSweeney, SZ Pavletic, KR Maravilla, M Park, ...
Blood 102 (7), 2364-2372, 2003
2872003
National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 ancillary therapy and supportive …
PA Carpenter, CL Kitko, S Elad, MED Flowers, JC Gea-Banacloche, ...
Biology of Blood and Marrow Transplantation 21 (7), 1167-1187, 2015
2712015
The system can't perform the operation now. Try again later.
Articles 1–20